Biotech company Amgen (NASDAQ:AMGN) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35 billion, close to analysts’ estimates. Its non-GAAP profit of $4.90 per share was 15% above analysts’ consensus estimates.
Casino resort and entertainment company Red Rock Resorts (NASDAQ:RRR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.8% year on year to $497.9 million. Its non-GAAP profit of $0.51 per share was 12.9% above analysts’ consensus estimates.
Video game publisher Take Two (NASDAQ:TTWO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.1% year on year to $1.58 billion. The company expects next quarter’s revenue to be around $1.38 billion, coming in 4.7% above analysts’ estimates. Its GAAP loss of $21.08 per share was significantly below analysts’ consensus estimates.
Mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 28.1% year on year to $331.8 million. Its GAAP profit of $0.22 per share was 64.5% above analysts’ consensus estimates.
Healthcare professional network Doximity (NYSE:DOCS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 17.1% year on year to $138.3 million. On the other hand, next quarter’s revenue guidance of $139.5 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 39.3% above analysts’ consensus estimates.
Semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.8% year on year to $7.1 billion. The company expects next quarter’s revenue to be around $7.2 billion, coming in 0.5% above analysts’ estimates. Its non-GAAP profit of $2.39 per share was 3.4% above analysts’ consensus estimates.
Security and healthcare technology company OSI Systems (NASDAQ:OSIS) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.6% year on year to $444.4 million. The company expects the full year’s revenue to be around $1.7 billion, close to analysts’ estimates. Its non-GAAP profit of $2.44 per share was 1.5% above analysts’ consensus estimates.
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Resource management provider Itron (NASDAQ:ITRI) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $607.2 million. On the other hand, the company expects next quarter’s revenue to be around $610 million, close to analysts’ estimates. Its non-GAAP profit of $1.52 per share was 15.3% above analysts’ consensus estimates.
In April, Trump’s tariffs pushed the VIX top 60 during a flat-out market rout, but just a few weeks later… we’re seeing some of the lowest volatility we’ve had all year.
Economic consulting firm CRA International (NASDAQ:CRAI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.9% year on year to $181.9 million. The company’s full-year revenue guidance of $725 million at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP profit of $2.22 per share was 13.8% above analysts’ consensus estimates.
Global electronics components and solutions distributor Arrow Electronics (NYSE:ARW) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $6.81 billion. On the other hand, next quarter’s revenue guidance of $7 billion was less impressive, coming in 1.4% below analysts’ estimates. Its non-GAAP profit of $1.80 per share was 25.5% above analysts’ consensus estimates.
